Table: Jcr Pharmaceuticals - 6-MTH group results

JCR Pharmaceuticals

30/10/2025 05:00

Oct 30 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               21.36               16.66            37.80    
                   (+28.2 pct)         (-31.4 pct)      (+14.3 pct) 
  Operating            2.38           loss 739 mln          2.60    
  Recurring            2.36             loss 1.62           2.40    
  Net                  1.71           loss 691 mln          3.00    
  EPS               14.03 yen         loss 5.53 yen      24.22 yen  
  EPS Diluted       14.03 yen                                       
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T